A VISION Substudy of Reader Agreement on<sup>68</sup>Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for<sup>177</sup>Lu-PSMA-617 Radioligand Therapy-Reference-Cited by-同舟云学术

A VISION Substudy of Reader Agreement on⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for¹⁷⁷Lu-PSMA-617 Radioligand Therapy

Published:2023-05-25 Issue:8 Volume:64 Page:1259-1265
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kuo Phillip H.,Yoo Don C.,Avery Ryan,Seltzer Marc,Calais Jeremie,Nagarajah James,Weber Wolfgang A.,Fendler Wolfgang P.,Hofman Michael S.,Krause Bernd J.,Brackman Marcia,Kpamegan Euloge,Ghebremariam Samson,Benson Taylor,Catafau Ana M.,Kendi Ayse T.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference17 articles.

1. Constitutive and antibody-induced internalization of prostate-specific membrane antigen;Liu;Cancer Res.,1998

2. High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

3. Taxanes in the management of metastatic castration-resistant prostate cancer: Efficacy and management of toxicity

4. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

5. Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative ⁶⁸Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following ¹⁷⁷Lu-PSMA-617 (VISION Trial);Radiology;2024-08-01

2. PSMA-based therapeutics for prostate cancer;Expert Opinion on Pharmacotherapy;2024-07-02

3. Interreader and Intrareader Reproducibility of¹⁸F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies;Journal of Nuclear Medicine;2024-06-13

4. Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy;Radiology;2024-04-01

5. Clinical Positron Emission Tomography/Computed Tomography;PET Clinics;2024-04